Details of the Drug Reposition

General Information of This Drug (ID: DM9TD2N)

Drug Name
GD2 T cells   DM9TD2N
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Osteosarcoma DISLQ7E2 2B51 Phase 1 [1]
Neuroblastoma DISVZBI4 2D11.2 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01953900) iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma